Singapore markets close in 5 hours 48 minutes

Rani Therapeutics Holdings, Inc. (RANI)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
3.8200+0.0200 (+0.53%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-33,081
-33,970
-30,588
-8,331
0
-
Depreciation & amortisation
882
822
548
497
589
-
Stock-based compensation
18,463
19,008
15,782
22,595
0
-
Change in working capital
-1,433
-2,140
509
-3,429
1,044
-
Accounts payable
-513
-595
163
543
933
-
Other working capital
-49,483
-52,465
-48,134
-32,751
-16,160
-
Other non-cash items
1,391
1,273
841
109
47
-
Net cash provided by operating activities
-48,484
-51,236
-46,515
-32,245
-14,960
-
Cash flows from investing activities
Investments in property, plant and equipment
-999
-1,229
-1,619
-506
-1,200
-
Purchases of investments
-64,670
-73,261
-73,817
0
-
-
Sales/maturities of investments
101,700
104,350
3,000
0
-
-
Net cash used for investing activities
36,031
29,860
-72,436
-506
-1,200
-
Cash flows from financing activities
Debt repayment
-
-
0
-4,568
0
-
Common stock issued
-
-
0
73,648
0
-
Other financing activities
-
-162
-886
-
156
852
Net cash used provided by (used for) financing activities
346
233
29,005
77,146
72,682
-
Net change in cash
-12,107
-21,143
-89,946
44,395
56,522
-
Cash at beginning of period
19,484
27,507
117,453
73,058
16,536
-
Cash at end of period
7,377
6,364
27,507
117,453
73,058
-
Free cash flow
Operating cash flow
-48,484
-51,236
-46,515
-32,245
-14,960
-
Capital expenditure
-999
-1,229
-1,619
-506
-1,200
-
Free cash flow
-49,483
-52,465
-48,134
-32,751
-16,160
-